Literature DB >> 33488707

Development and Validation of a Nomogram to Predict Type 2 Diabetes Mellitus in Overweight and Obese Adults: A Prospective Cohort Study from 82938 Adults in China.

Qingqing Liu1, Jie Yuan1, Maerjiaen Bakeyi2, Jie Li1, Zilong Zhang1, Xiaohong Yang3, Fangming Gao1.   

Abstract

BACKGROUND: The twin epidemic of overweight/obesity and type 2 diabetes mellitus (T2DM) is a major public health problem globally, especially in China. Overweight/obese adults commonly coexist with T2DM, which is closely related to adverse health outcomes. Therefore, this study aimed to develop risk nomogram of T2DM in Chinese adults with overweight/obesity.
METHODS: We used prospective cohort study data for 82938 individuals aged ≥20 years free of T2DM collected between 2010 and 2016 and divided them into a training (n = 58056) and a validation set (n = 24882). Using the least absolute shrinkage and selection operator (LASSO) regression model in training set, we identified optimized risk factors of T2DM, followed by the establishment of T2DM prediction nomogram. The discriminative ability, calibration, and clinical usefulness of nomogram were assessed. The results were assessed by internal validation in validation set.
RESULTS: Six independent risk factors of T2DM were identified and entered into the nomogram including age, body mass index, fasting plasma glucose, total cholesterol, triglycerides, and family history. The nomogram incorporating these six risk factors showed good discrimination regarding the training set, with a Harrell's concordance index (C-index) of 0.859 [95% confidence interval (CI): 0.850-0.868] and an area under the receiver operating characteristic curve of 0.862 (95% CI: 0.853-0.871). The calibration curves indicated well agreement between the probability as predicted by the nomogram and the actual probability. Decision curve analysis demonstrated that the prediction nomogram was clinically useful. The consistent of findings was confirmed using the validation set.
CONCLUSIONS: The nomogram showed accurate prediction for T2DM among Chinese population with overweight and obese and might aid in assessment risk of T2DM.
Copyright © 2020 Qingqing Liu et al.

Entities:  

Year:  2020        PMID: 33488707      PMCID: PMC7775153          DOI: 10.1155/2020/8899556

Source DB:  PubMed          Journal:  Int J Endocrinol        ISSN: 1687-8337            Impact factor:   3.257


  35 in total

1.  A simple Chinese risk score for undiagnosed diabetes.

Authors:  W G Gao; Y H Dong; Z C Pang; H R Nan; S J Wang; J Ren; L Zhang; J Tuomilehto; Q Qiao
Journal:  Diabet Med       Date:  2010-03       Impact factor: 4.359

2.  The effects of high glucose exposure on global gene expression and DNA methylation in human pancreatic islets.

Authors:  Elin Hall; Marloes Dekker Nitert; Petr Volkov; Siri Malmgren; Hindrik Mulder; Karl Bacos; Charlotte Ling
Journal:  Mol Cell Endocrinol       Date:  2017-11-26       Impact factor: 4.102

3.  Novel nomogram for screening the risk of developing diabetes in a Korean population.

Authors:  Seung Min Chung; Jae Cheol Park; Jun Sung Moon; Jea Young Lee
Journal:  Diabetes Res Clin Pract       Date:  2018-06-07       Impact factor: 5.602

4.  [Validation of lipids on body mass index reference recommended by Obesity Working Group, International Life Science Association of China].

Authors:  Feng-ying Zhai; Li-wei Zhang; Chun-rong Wang; Jia-li Duan; Ruo-xiang Cao; Hui-jun Wang; Jian Zhang
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2004-02

5.  The associations of body mass index, C-peptide and metabolic status in Chinese Type 2 diabetic patients.

Authors:  W B Chan; P C Y Tong; C C Chow; W Y So; M C Y Ng; R C W Ma; R Osaki; C S Cockram; J C N Chan
Journal:  Diabet Med       Date:  2004-04       Impact factor: 4.359

6.  Determinants of the calibration of SAPS II and SAPS 3 mortality scores in intensive care: a European multicenter study.

Authors:  Antoine Poncet; Thomas V Perneger; Paolo Merlani; Maurizia Capuzzo; Christophe Combescure
Journal:  Crit Care       Date:  2017-04-04       Impact factor: 9.097

7.  Development and validation of the DIabetes Severity SCOre (DISSCO) in 139 626 individuals with type 2 diabetes: a retrospective cohort study.

Authors:  Salwa S Zghebi; Mamas A Mamas; Darren M Ashcroft; Chris Salisbury; Christian D Mallen; Carolyn A Chew-Graham; David Reeves; Harm Van Marwijk; Nadeem Qureshi; Stephen Weng; Tim Holt; Iain Buchan; Niels Peek; Sally Giles; Martin K Rutter; Evangelos Kontopantelis
Journal:  BMJ Open Diabetes Res Care       Date:  2020-05

8.  Association of body mass index and age with incident diabetes in Chinese adults: a population-based cohort study.

Authors:  Ying Chen; Xiao-Ping Zhang; Jie Yuan; Shi-Wei Cui; Zhi-Qiang Lu; Xiao-Ying Li; Bo Cai; Xiao-Li Wang; Xiao-Li Wu; Yue-Hua Zhang; Xiao-Yi Zhang; Tong Yin; Xiao-Hui Zhu; Yun-Juan Gu
Journal:  BMJ Open       Date:  2018-09-28       Impact factor: 2.692

9.  Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  BMJ       Date:  2017-11-20

10.  Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

Authors: 
Journal:  Lancet       Date:  2016-04-06       Impact factor: 79.321

View more
  1 in total

1.  Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.

Authors:  Shishi Xu; Ruth L Coleman; Qin Wan; Yeqing Gu; Ge Meng; Kun Song; Zumin Shi; Qian Xie; Jaakko Tuomilehto; Rury R Holman; Kaijun Niu; Nanwei Tong
Journal:  Cardiovasc Diabetol       Date:  2022-09-13       Impact factor: 8.949

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.